COP 📈 CompuGroup Medical SE & - Overview

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000A288904

COP: Software, Healthcare, Medical, Hospital, Pharmacy, Management, Systems

CompuGroup Medical SE & Co. KGaA provides e-health services worldwide. It operates through Ambulatory Information Systems, Hospital Information Systems, Consumer and Health Management Information Systems, and Pharmacy Information Systems segments. The Ambulatory Information Systems segment develops and sells practice management software for registered physicians, medical care centers, and physician networks; offers supplementary app, internet, and intranet solutions; and delivers solutions for medical facilities, such as medica; care centers and practice associations. The Hospital Information Systems segment develop and sells of clinical and administrative solutions for inpatient sector; provides software solutions for administration, planning and provision of care in outpatient and inpatient medical facilities; and healthcare services to acute care hospitals, rehabilitation centers, welfare institutions, multi-location hospital networks, healthcare regions, regional care organizations, medical laboratories, and radiologists. The Consumer and Health Management Information Systems segment provides software interfaces for data exchange, portals for retrieving data from the German outpatient healthcare market, medical decision support tools, medication and treatment databases for healthcare service providers, solutions for the insurance industry, and digital healthcare applications, patient portals, and mobile apps; and operates telematics infrastructure business, that offers secure links, as well as security solutions for service providers. The Pharmacy Information Systems segment develop and sell administrative and billing related software applications, including procuring and shipping, managing and controlling inventory, planning, performing, and monitoring retail activities for pharmacies. The company was founded in 1987 and is headquartered in Koblenz, Germany. Web URL: https://www.cgm.com

Additional Sources for COP Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

COP Stock Overview

Market Cap in USD 804m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Technology
IPO / Inception

COP Stock Ratings

Growth 5y -90.1%
Fundamental 4.18%
Dividend 42.5%
Rel. Strength Industry -1759
Analysts -
Fair Price Momentum 19.12 EUR
Fair Price DCF 30.09 EUR

COP Dividends

Dividend Yield 12m 4.60%
Yield on Cost 5y 1.70%
Annual Growth 5y 0.00%
Payout Consistency 60.2%

COP Growth Ratios

Growth Correlation 3m 80.2%
Growth Correlation 12m -88%
Growth Correlation 5y -86.8%
CAGR 5y -17.84%
CAGR/Mean DD 5y -0.48
Sharpe Ratio 12m -0.64
Alpha -62.37
Beta 0.80
Volatility 37.05%
Current Volume 901.8k
Average Volume 20d 919.2k
What is the price of COP stocks?
As of December 22, 2024, the stock is trading at EUR 21.74 with a total of 901,751 shares traded.
Over the past week, the price has changed by +0.28%, over one month by +54.86%, over three months by +55.08% and over the past year by -38.68%.
Is CompuGroup Medical SE & a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, CompuGroup Medical SE & is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 4.18 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of COP as of December 2024 is 19.12. This means that COP is currently overvalued and has a potential downside of -12.05%.
Is COP a buy, sell or hold?
CompuGroup Medical SE & has no consensus analysts rating.
What are the forecast for COP stock price target?
According to ValueRays Forecast Model, COP CompuGroup Medical SE & will be worth about 20.7 in December 2025. The stock is currently trading at 21.74. This means that the stock has a potential downside of -5.01%.
Issuer Forecast Upside
Wallstreet Target Price 25.5 17.3%
Analysts Target Price - -
ValueRay Target Price 20.7 -5%